
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7395475
[patent_doc_number] => 20040018195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Diabetes-related immunoglobulin derived proteins, compositions, methods and uses'
[patent_app_type] => new
[patent_app_number] => 10/397786
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30308
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10397786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/397786 | Diabetes-related immunoglobulin derived proteins, compositions, methods and uses | Mar 25, 2003 | Abandoned |
Array
(
[id] => 6829273
[patent_doc_number] => 20030180331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Facilitation of wound healing with CM101/GBS toxin'
[patent_app_type] => new
[patent_app_number] => 10/396770
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5059
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10396770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/396770 | Facilitation of wound healing with CM101/GBS toxin | Mar 23, 2003 | Abandoned |
Array
(
[id] => 7290730
[patent_doc_number] => 20040110673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases'
[patent_app_type] => new
[patent_app_number] => 10/382397
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12491
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110673.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382397 | Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same | Mar 5, 2003 | Issued |
Array
(
[id] => 6769499
[patent_doc_number] => 20030215439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Therapeutic uses of PAF-AH products in diabetes'
[patent_app_type] => new
[patent_app_number] => 10/373639
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7261
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373639
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373639 | Therapeutic uses of PAF-AH products in diabetes | Feb 23, 2003 | Abandoned |
Array
(
[id] => 5743577
[patent_doc_number] => 20060089302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/505848
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10917
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505848 | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases | Feb 23, 2003 | Abandoned |
Array
(
[id] => 6730250
[patent_doc_number] => 20030186440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Maturation of dendritic cells with immune response modifying compounds'
[patent_app_type] => new
[patent_app_number] => 10/354767
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11241
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10354767
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/354767 | Maturation of dendritic cells with immune response modifying compounds | Jan 29, 2003 | Abandoned |
Array
(
[id] => 6822068
[patent_doc_number] => 20030220229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Proinsulin peptide compounds for detecting and treating type I diabetes'
[patent_app_type] => new
[patent_app_number] => 10/346563
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14796
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10346563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/346563 | Proinsulin peptide compounds for detecting and treating type I diabetes | Jan 15, 2003 | Abandoned |
Array
(
[id] => 6990811
[patent_doc_number] => 20050089848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnonsis of autoimmune diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/345307
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6755
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345307
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345307 | DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes | Jan 15, 2003 | Issued |
Array
(
[id] => 6724989
[patent_doc_number] => 20030207301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Assay for the detection of factors that modulate the expression of INGAP'
[patent_app_type] => new
[patent_app_number] => 10/339767
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15998
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339767
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339767 | Regulatory sequences for modulation of INGAP expression and reporter constructs | Jan 8, 2003 | Issued |
Array
(
[id] => 6669662
[patent_doc_number] => 20030114646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Human cystatin F'
[patent_app_type] => new
[patent_app_number] => 10/329428
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23289
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10329428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/329428 | Human cystatin F | Dec 26, 2002 | Abandoned |
Array
(
[id] => 7356057
[patent_doc_number] => 20040013676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same'
[patent_app_type] => new
[patent_app_number] => 10/312512
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10451
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013676.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312512 | Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same | Dec 26, 2002 | Abandoned |
Array
(
[id] => 7432570
[patent_doc_number] => 20040002113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Detection and treatment methods for type I diabetes'
[patent_app_type] => new
[patent_app_number] => 10/321717
[patent_app_country] => US
[patent_app_date] => 2002-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14721
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10321717
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/321717 | Detection and treatment methods for type I diabetes | Dec 16, 2002 | Abandoned |
Array
(
[id] => 130780
[patent_doc_number] => 07700102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Nucleic acids encoding CD100 molecules'
[patent_app_type] => utility
[patent_app_number] => 10/320769
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 15
[patent_no_of_words] => 28928
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10320769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/320769 | Nucleic acids encoding CD100 molecules | Dec 15, 2002 | Issued |
Array
(
[id] => 6972246
[patent_doc_number] => 20050037956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Screening method for agents useful in treating diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/498587
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498587 | Screening method for agents useful in treating diabetes | Dec 12, 2002 | Abandoned |
Array
(
[id] => 7116239
[patent_doc_number] => 20050069540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Treating b-cell mediated diseases by modulating dr6 activity'
[patent_app_type] => utility
[patent_app_number] => 10/480109
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23489
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480109 | Treating b-cell mediated diseases by modulating dr6 activity | Dec 9, 2002 | Abandoned |
Array
(
[id] => 544850
[patent_doc_number] => 07169898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells'
[patent_app_type] => utility
[patent_app_number] => 10/309611
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11892
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309611 | Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells | Dec 3, 2002 | Issued |
Array
(
[id] => 6864797
[patent_doc_number] => 20030190323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Preparations and methods for the treatment of T cell mediated diseases'
[patent_app_type] => new
[patent_app_number] => 10/307326
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10873
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10307326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/307326 | Preparations and methods for the treatment of T cell mediated diseases | Dec 1, 2002 | Abandoned |
Array
(
[id] => 6710490
[patent_doc_number] => 20030170239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Immunotherapeutic method to prevent islet cell rejection'
[patent_app_type] => new
[patent_app_number] => 10/306860
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12044
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306860 | Immunotherapeutic method to prevent islet cell rejection | Nov 25, 2002 | Abandoned |
Array
(
[id] => 7429244
[patent_doc_number] => 20040001806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Preparation of dendritic cells from spinal cord stem cells'
[patent_app_type] => new
[patent_app_number] => 10/292152
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3474
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292152
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292152 | Preparation of dendritic cells from spinal cord stem cells | Nov 11, 2002 | Abandoned |
Array
(
[id] => 7155917
[patent_doc_number] => 20050026854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Selective elimination of cd52and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/495084
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9294
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495084
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495084 | Selective elimination of cd52and uses thereof | Oct 31, 2002 | Abandoned |